PLEASANTON, Calif.--QLT Ophthalmics, Inc. (QOI), a wholly-owned U.S. subsidiary of QLT Inc. (NASDAQ: QLTI; TSX: QLT), selected Veeva System’s multi-tenant SaaS CRM system built on the cloud computing model. QOI was formed by QLT Inc. in Q4 2009 to take over the sales and marketing of Visudyne® in the U.S. from Novartis Pharma AG (“Novartis”). Veeva CRM™ proved the only system flexible and scalable enough to meet QOI’s rapidly growing needs, according to QOI’s Director of Commercial Operations, Scott Jones.

“Veeva CRM is easily scalable, which was very important to us as we hope to scale-up our commercial operations as we bring new therapeutics to the market”

“Veeva CRM is easily scalable, which was very important to us as we hope to scale-up our commercial operations as we bring new therapeutics to the market,” said Jones. “Plus, the Veeva CRM system is as flexible in its pricing model as it is technologically. We didn’t have to make a huge investment in Veeva up-front but when we are ready for more ‘system’ with additional functionality and seat licenses, we can pay incrementally to build on and not have wasted any money with our initial outlay.”

The ophthalmic pharmaceutical company went live with the complete Veeva CRM suite in February. A multi-tenant SaaS application built on the cloud computing model, Veeva CRM requires no hardware or software to purchase, scale, or maintain. Plus, customers benefit from free, automatic upgrades every 90 days so users will always be working on the latest version of the software with the very latest compliance changes and system enhancements– all very appealing to small companies like QOI.

“We looked at most of the Pharma CRM vendors, but knew fairly quickly that Veeva was the best fit for us. The fact that they were able to implement the system in less than 6 weeks was the final feather in their cap,” concluded Jones.

About Veeva CRM

The Veeva CRM suite of applications, comprised of VBioPharma™, VMobile™, and VInsights™, is the life sciences industry’s top multi-tenant SaaS-based CRM solution. As the foundation, VBioPharma offers multiple editions in one CRM product to accommodate the unique needs of various life sciences commercial teams. It is also the only Pharma CRM application to come pre-validated for PDMA and 21 CFR Part 11 compliance. The complete Veeva CRM suite gives customers the mobility and reporting solutions needed to drive user adoption and sales effectiveness.

About Veeva Systems

Veeva Systems is the leader in multi-tenant SaaS-based solutions for the global life sciences industry. Veeva has dozens of customers ranging from the world’s largest pharmaceutical companies with thousands of users to emerging biotechs commercializing their first products. Veeva customers achieve the fastest time to value through the deployment of fully functional applications that are flexible, simple to deploy, inexpensive to operate, and provide a superior user experience. Veeva is a privately-held company headquartered in Pleasanton, CA. For more information, visit www.veevasystems.com.

About QLT Ophthalmics, Inc. (QOI)

QOI is a wholly-owned U.S. subsidiary of QLT Inc. QOI was formed to commercialize QLT pharmaceutical and device products for the ophthalmic community. QOI’s current mission is to support and market Visudyne across the United States.